NIRV Share Price Performance
CA$0.14
-0.11 (-44.00%)
Price CA$0.14
Share PriceCA$0.14
Nirvana Life Sciences Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
NIRV Community Narratives
There are no narratives available yet.
Recent NIRV News & Updates
Nirvana Life Sciences Inc. Key Details
Last Reported Earnings
Jul 31, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.015
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- -19.9%
Nirvana Life Sciences Inc. Competitors
Snowflake Analysis
About NIRV
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
Nirvana Life Sciences Inc. engages in the research and development of therapeutic products and medicines to address addiction. It also provides gel caps transition from opioids to non-addictive pain relief therapies. The company is headquartered in Vancouver, Canada.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Canadian Market Performance
- 7 Days: 0.3%
- 3 Months: 10.0%
- 1 Year: 20.8%
- Year to Date: 20.1%
Over the last 7 days, the market has remained flat, although notably the Healthcare sector declined by 3.5%. As for the longer term, the market has risen 21% in the past 12 months. Looking forward, earnings are forecast to grow by 12% annually. Market details ›